Related Experiment Video

Updated: Jul 8, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Stem-cell therapy for diabetes cure: how close are we?

Anandwardhan A Hardikar1, Justin G Lees, Kuldip S Sidhu

  • 1Stem Cells and Diabetes Section, Lab # 10, National Centre for Cell Science, Ganeshkhind Road, Pune 411007, India. anand@nccs.res.i

Current Stem Cell Research & Therapy
|January 29, 2008
PubMed

Insights

Researchers are exploring stem cells for diabetes treatment due to limited donor islet cells. While expanding these cells is possible, directing their differentiation into insulin-producing cells remains a challenge for clinical application.

Area of Science:

  • Regenerative Medicine
  • Endocrinology
  • Stem Cell Biology

Background:

  • Type 1 diabetes treatment relies on insulin-producing cells, but donor cell scarcity is a major limitation.
  • Stem cells offer a potential alternative source for generating insulin-producing cells.
  • Current methods struggle with efficient and directed differentiation of stem cells into pancreatic endocrine lineages.

Purpose of the Study:

  • To review sources of pancreatic islet stem cells from human tissues.
  • To assess progress in pancreatic islet progenitor cell differentiation over the past two decades.
  • To evaluate the clinical translatability of stem cell-based diabetes therapies.

Main Methods:

  • Review of scientific literature on pancreatic islet stem cells.
  • Analysis of studies on in vitro expansion and differentiation of progenitor/stem cells.
  • Discussion of various human tissue sources for islet stem cells (embryonic, fetal, adult).

Main Results:

  • Identification of various pancreatic islet stem cell populations from human embryonic, fetal, and adult tissues.
  • Demonstration of in vitro expansion capabilities of progenitor/stem cell populations.
  • Highlighting persistent difficulties in achieving efficient and directed differentiation towards endocrine pancreatic lineages.

Conclusions:

  • Stem cells represent a promising, albeit challenging, avenue for addressing donor cell limitations in diabetes therapy.
  • Significant progress has been made in understanding and expanding islet progenitor cells.
  • Further research is needed to overcome differentiation hurdles for successful clinical translation.

More Related Videos

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...